
CS Medica Investor Relations Material
Latest events

Q2 2024
CS Medica

Q4 2024
30 Nov, 2024

Q3 2024
16 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CS Medica
Access all reports
CS MEDICA is a Danish MedTech company that specializes in the research, development, manufacturing, and commercialization of medical products incorporating cannabinoids derived from the cannabis plant. The company focuses on creating innovative treatment solutions and skincare products utilizing natural Cannabidiol (CBD) to offer efficient and safe treatments for autoimmune and stress-related disorders. CS MEDICA's approach combines science and nature to provide products aimed at improving everyday life for its customers. The company's medical collection includes over-the-counter (OTC) CBD medical products and cosmetics. The company is headquartered in Copenhagen, Denmark, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CSMED
Country
🇩🇰 Denmark